IP Library › Assignment 032897/0450
Patent Assignment
Reel/Frame 032897/0450

Address Change

Recorded: 2014-05-15 Received: 2014-05-15 Pages: 3
Assignor
Assignee
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, CAX, H7L 4A8, CANADA
Covered Properties (22)
Vision Through Photodynamic Therapy of the Eye
Application: 13/584,617 →
Method for Treating Neovascularization
Application: 13/448,242 →
Photodynamic Therapy Laser
Application: 13/426,470 →
Photodynamic Therapy for Conditions of the Eye
Application: 13/140,411 →
Drug Delivery System for Hydrophobic Drugs
Application: 12/487,964 →
Photodynamic therapy for the treatment of acne
Application: 10/588,571 →
Method for Treating Neovascularization
Application: 11/975,325 →
Photodynamic Therapy For The Treatment Of Hyperactive Sebaceous Gland Disorders Using Topically Applied Hydrophobic Green Porphyrins
Application: 10/588,419 →
Vision Through Photodynamic Therapy of the Eye
Application: 11/852,965 →
Immuno-Adjuvant Pdt Treatment of Metastatic Tumors
Application: 10/985,582 →
Ethylene Glycol Esters as Photoactive Agents
Application: 10/825,270 →
Reduced Fluence Rate Pdt
Application: 10/641,885 →
Treatment of Macular Edema
Application: 10/622,310 →
Compositions and Methods for Delivery of Photosensitive Drugs
Application: 10/440,505 →
PEG-lipid containing formulations
Application: 10/286,963 →
Treatment of Macular Edema
Application: 10/199,662 →
Method for Reducing or Preventing Pdt Related Inflammation
Application: 10/081,010 →
Method to Prevent Vision Loss
Application: 10/072,215 →
Photodynamic Therapy of Occult Age-Related Macular Degeneration
Application: 10/072,272 →
Reduced Fluence Rate Pdt
Application: 10/072,009 →
Methods, Compositions and Articles for Reducing or Preventing the Effects of Inflammation
Application: 09/929,558 →
Drug Delivery System for Hydrophobic Drugs
Application: 09/833,406 →